Current Hepatitis Reports

, Volume 12, Issue 1, pp 53–58

DILI: New Insights into Diagnosis and Management

Authors

  • Thanh Tran
    • Department of Internal MedicineUniversity of Texas Southwestern Medical Center at Dallas
    • Department of Internal MedicineUniversity of Texas Southwestern Medical Center at Dallas
    • Digestive and Liver Diseases DivisionUT Southwestern Medical Center at Dallas
Complex Clinical Issues (SA Harrison and NS Reau, Section Editors)

DOI: 10.1007/s11901-012-0159-x

Cite this article as:
Tran, T. & Lee, W.M. Curr Hepatitis Rep (2013) 12: 53. doi:10.1007/s11901-012-0159-x

Abstract

Drug-induced liver injury continues to have a significant impact. With over 1000 drugs now registered as causing DILI, this form of liver injury is the most cited reason for withdrawal of a drug from the marketplace. Despite this, the diagnosis of DILI continues to rely on subjective measures and expert opinion with results that are both difficult to verify and reproduce. However, recent developments in DILI research may provide new insights to improve diagnosis and treatment in the future.

Keywords

BiotransformationAcetaminophenHerbal and dietary supplementsGenome wide association studyGenetic polymorphism

Copyright information

© Springer Science+Business Media New York 2013